Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeGeRN in R/R DLBCL
NCT03259529Phase 2Completed
- Sponsor
- First Saint Petersburg State Medical University
- Start
- Mar 2017
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in diffuse large B-cell lymphoma (DLBCL), sponsored by First Saint Petersburg State Medical University. Started Mar 2017; status: completed.
02
Drugs
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03259529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259529.